Rheumatoid Arthritis (RA) is one of the most common auto-immune diseases. Early diagnosis can have a significant impact on the treatment and progression of the disease. Novio Catalpa has developed a rapid test for diagnosing RA. The patented test is user friendly and suitable for point-of-care testing. 
For the development Novio Catalpa cooperates with the Department of Biomolecular Chemistry of the Radboud University. The scientists involved have key knowledge for the detection of antibodies related to auto-immune disorders.

Health Data

Health Diagnostics

Therapeutics

Clinical Trials

Life Sciences

Health Care

Biotechnology

Novio Catalpa

Martin Salden

René Reijtenbagh

Novio Catalpa

Org chart

Similar companies